VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,000 | +25.0% | 121,273 | 0.0% | 0.00% | – |
Q4 2022 | $12,000 | -47.8% | 121,273 | -22.9% | 0.00% | – |
Q3 2022 | $23,000 | -83.8% | 157,273 | -3.0% | 0.00% | – |
Q2 2022 | $142,000 | -29.0% | 162,078 | 0.0% | 0.00% | – |
Q1 2022 | $200,000 | -24.8% | 162,078 | +19.1% | 0.00% | -100.0% |
Q4 2021 | $266,000 | -28.5% | 136,078 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $372,000 | -13.3% | 136,078 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $429,000 | +59.5% | 136,078 | +7.9% | 0.00% | 0.0% |
Q1 2021 | $269,000 | +192.4% | 126,078 | -4.7% | 0.00% | – |
Q3 2020 | $92,000 | +31.4% | 132,328 | 0.0% | 0.00% | – |
Q2 2020 | $70,000 | +20.7% | 132,328 | 0.0% | 0.00% | – |
Q1 2020 | $58,000 | -36.3% | 132,328 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $91,000 | -35.9% | 132,328 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $142,000 | +47.9% | 132,328 | -0.0% | 0.00% | 0.0% |
Q2 2019 | $96,000 | +146.2% | 132,353 | +326.3% | 0.00% | – |
Q1 2019 | $39,000 | -15.2% | 31,045 | -0.8% | 0.00% | – |
Q4 2018 | $46,000 | +35.3% | 31,295 | +31.9% | 0.00% | – |
Q3 2018 | $34,000 | +6.2% | 23,726 | 0.0% | 0.00% | – |
Q2 2018 | $32,000 | +68.4% | 23,726 | +12.2% | 0.00% | – |
Q1 2018 | $19,000 | -13.6% | 21,149 | +4.6% | 0.00% | – |
Q4 2017 | $22,000 | -31.2% | 20,215 | 0.0% | 0.00% | – |
Q3 2017 | $32,000 | -15.8% | 20,215 | 0.0% | 0.00% | – |
Q2 2017 | $38,000 | -2.6% | 20,215 | 0.0% | 0.00% | – |
Q1 2017 | $39,000 | -48.0% | 20,215 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $75,000 | -12.8% | 20,215 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $86,000 | +8.9% | 20,215 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $79,000 | – | 20,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|